Decision Makers
| Name (plus bio) |
Position |
| Bruce L.A. Carter |
Chief Executive Officer |
| Stephen W. Zaruby |
President |
| Doug E Williams |
Chief Scientific Officer |
| Douglas E. Williams |
Chief Scientific Officer |
| Frank D. Collins |
Senior Vice President of Research and Chief |
| James A. Johnson |
Cfo, Treasurer & Executive Vice President |
| James J. Johnson |
CFO, Senior Vice President & Treasurer |
| Darren R. Hamby |
Senior Vice President, Hr |
| Heather L Franklin |
Senior Vice President, Business Development |
| Jan K Ohrstrom |
Senior Vice President, Commercial Operations |
| Mark D. Young |
Senior Vice President, Technical Operations |
| Michael Dwyer |
Senior Vice President, Sales & Marketing |
| Suzanne M. Shema |
General Counsel & Senior Vice President, Law, Compliance |
| Vaughn B. Himes |
Senior Vice President, Technical Operations |
| Gregory R Wade |
Piper Jaffray and Co. Edward Tenthoff |
| Michael C Maloney |
Senior Regulatory Affairs Specialist |
| Susan Specht |
Associate |
| David I. Hirsh |
Director |
| James A. Harper |
Director |
| Jonathan Leff Warburg |
Director |
Board of Directors
Dr. Bruce L.A. Carter was appointed as an Additional Director on the Board of the Company effective July 21, 2008. Dr. Carter is the Chairman of the Board and the Chief Executive Officer of ZymoGenetics, Inc. Seattle, Washington, USA. Dr. Carter was appointed Chairman of ZymoGenetics in April, 2008 and has been the Chief Executive Officer of ZymoGenetics, Inc. since April, 1998. He joined ZymoGenetics in 1986 first as Vice-President of Research and Development. In 1994, he was chosen as Corporate Executive Vice-President and Chief Scientific Officer for Novo Nordisk A/S, the former parent company of Zymogenetics. He was elected to the Board of ZymoGenetics in 1987 and was appointed President of the company in 1998. Dr. Carter led the negotiations that established Zymogenetics as an independent company from Novo Nordisk in 2000. Dr. carter held various positions of increasing responsibility at G.D.Searle & Co. Ltd. from 1982-1986 and was a lecturer at Trinity College, University of Dublin from 1975-1982. Dr. Carter is a B.Sc. Botany (Honors) from University of Nottingham, England, and a Ph.D. in Microbiology from Queen Elizabeth College, University of London.
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Chief Executive Officer |
Current |
| ZymoGenetics, Inc. |
Vice President, Research and Development |
Former |
| ZymoGenetics, Inc. |
Chairman of The Board |
Current |
| Biotechnology, Inc. |
Board of Directors |
Current |
| Biotechnology Industry Organization |
Director |
Current |
| Washington Biotechnology & Biomedical Association |
Director |
Current |
| Dr. Reddy's Laboratories Limited |
Board of Directors |
Current |
| QLT, Inc. |
Board of Directors |
Current |
| Trinity College |
Lecturer |
Former |
| Novo Nordisk, Inc. |
|
Former |
| ZymoGenetics, Inc. |
Board of Directors |
Former |
| University of London |
Ph.D. In Microbiology |
Former |
| University of Nottingham |
B.Sc. With Honors In Botany |
Former |
Stephen W. Zaruby has served as President of ZymoGenetics since January 2, 2009. Previously Mr. Zaruby served as Vice President, Global Head, Hospital/Surgical Business Unit, Haematology/Cardiology, with Bayer HealthCare Pharmaceuticals. In that role, he was the global strategic and U.S. operational head for hospital, surgical and related specialty products. Prior to that, he served as Director, Global Strategic Marketing for Bayer HealthCare Pharmaceuticals, where he oversaw global strategic marketing and commercialization platforms for the quinolone franchise. Previously, Mr. Zaruby held several other sales, marketing and product development positions within Bayer HealthCare and its affiliates. Mr. Zaruby earned a B.S. with Honors in Cellular, Molecular, and Microbiology from the University of Calgary in Calgary, Alberta.
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
President |
Current |
| University of Calgary |
B.Sc. |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Chief Scientific Officer |
Current |
| Immunex Corporation |
Chief Technology Officer |
Former |
| State University of New York at Buffalo |
Ph.D. in Physiology |
Former |
Douglas E. Williams, Ph.D., 50, has served as a member of our Board of Directors since April 2004. He currently serves as President of ZymoGenetics, Inc. From September 2003 to August 2004, Dr. Williams served as Seattle Genetics' Chief Scientific Officer, Executive Vice President and a member of their Board of Directors. Prior to joining Seattle Genetics, from November 2002 to August 2003, Dr. Williams was Head of Health and Strategic Development for Genesis Research & Development, a biotechnology company located in New Zealand. From July to October 2002, he served as Senior Vice President, Washington Site Leader and a member of the Executive Committee for Amgen, Inc. Dr. Williams joined Amgen in July 2002 when it acquired Immunex Corporation, where he worked for 14 years, most recently serving as Executive Vice President, Chief Technology Officer and a member of Immunex's Board of Directors. Prior to his work at Immunex, Dr. Williams served on the faculty of the Indiana University School of Medicine and the Department of Laboratory Medicine at the Roswell Park Memorial Institute. He serves on the boards of privately-held Aerovance, Inc. and of publicly traded Anadys Pharmaceuticals, Inc. and is a member of the Scientific Advisory Board of Symphony Capital. Dr. Williams holds a B.S. magna cum laude in Biological Sciences from the University of Massachusetts, Lowell and a Ph.D. in Physiology from the State University of New York at Buffalo, Roswell Park Division.
| Organization |
Position |
Status |
| Array BioPharma, Inc. |
President, Zymogenetics |
Current |
| ZymoGenetics, Inc. |
Chief Scientific Officer |
Current |
| ZymoGenetics, Inc. |
Executive Vice President, Research and Development |
Current |
| Symphony Capital LLC |
Board of Directors |
Current |
| Aerovance, Inc |
Board of Directors |
Current |
| Array BioPharma, Inc. |
Board of Directors |
Current |
| Anadys Pharmaceuticals, Inc. |
Board of Directors |
Current |
| Seattle Genetics, Inc. |
Board of Directors |
Current |
| Genesis Research and Development Corporation Limited |
Board of Directors |
Current |
| ZymoGenetics, Inc. |
Chief Executive Officer |
Former |
| Immunex Corporation |
Chief Technology Officer |
Former |
| Seattle Genetics, Inc. |
Chief Scientific Officer |
Former |
| Immunex Corporation |
Executive Vice President |
Former |
| Seattle Genetics, Inc. |
Executive Vice President, Research and Development |
Former |
| Amgen Inc. |
Senior Vice President |
Former |
| Immunex Corporation |
Senior Vice President of Discovery Research |
Former |
| Genesis Research and Development Corporation Limited |
Head of Health and Strategic Development |
Former |
| Genesis Research |
Head of Health and Strategic Development |
Former |
| Immunex Corporation |
Board of Directors |
Former |
| The State University of New York |
Ph.D. in Physiology |
Former |
| State University of New York at Buffalo |
Ph.D. In Physiology |
Former |
| University of Massachusetts Amherst |
B.S. Magna Cum Laude In Biological Sciences |
Former |
| Immunex Corporation |
Member |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Senior Vice President of Research and Chief |
Current |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Cfo, Treasurer & Executive Vice President |
Current |
| ZymoGenetics, Inc. |
Senior Vice President |
Current |
| Immunex Corporation |
Vice President of Finance |
Current |
| Arthur Young, Inc. |
Senior Auditor |
Former |
| ZymoGenetics, Inc. |
Treasurer |
Former |
| University of Washington |
B.A. In Business Administration |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
CFO, Senior Vice President & Treasurer |
Current |
| ZymoGenetics, Inc. |
Senior Vice President, CFO, Treasurer |
Current |
| Arthur Young, Inc. |
Senior Auditor |
Former |
| University of Washington |
B.A. in Business Administration |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Senior Vice President, Hr |
Current |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Senior Vice President, Business Development |
Current |
| ZymoGenetics, Inc. |
Director |
Former |
| Wharton Graduate School of the University of Pennsylvania |
M.B.A |
Former |
| University of Washington |
M.S. |
Former |
| University of North Carolina, Chapel Hill |
B.S. |
Former |
| Organization |
Position |
Status |
| Profibrix |
President |
Current |
| Profibrix |
Chief Operating Officer |
Current |
| MediQuest Therapeutics, Inc. |
Chief Clinical Officer |
Current |
| MediQuest Therapeutics, Inc. |
Executive Vice President |
Current |
| ZymoGenetics, Inc. |
Senior Vice President, Commercial Operations |
Current |
| Avigen, Inc. |
Board of Directors |
Current |
| Novo Nordisk, Inc. |
Head of Strategic Marketing |
Former |
| University of Copenhagen |
M.D. |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Senior Vice President, Technical Operations |
Current |
| Biomira Inc. |
Chief Operating Officer |
Former |
| University of Michigan |
Ph.D. In Chemical Engineering |
Former |
| Columbia University |
M.S. In Chemical Engineering |
Former |
| University of Nebraska |
B.S. In Chemical Engineering |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Senior Vice President, Sales & Marketing |
Current |
| Novo Nordisk, Inc. |
Vice President |
Former |
| Novo Nordisk, Inc. |
Board of Directors |
Former |
| Pepperdine University |
M.B.A. |
Former |
| University of Dayton |
B.S. |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
General Counsel & Senior Vice President, Law, Compliance |
Current |
| ZymoGenetics, Inc. |
Corporate Counsel |
Former |
| Research Corporation Technologies |
Associate General Counsel |
Former |
| Seed Company Limited |
Associate |
Former |
| University of Washington School of Law |
J.D. |
Former |
| University of Washington |
M.S. In Chemistry |
Former |
| The University of Texas |
B.S. In Chemistry |
Former |
Vaughn Himes joined Seattle Genetics in April 2009, bringing more than twenty years of experience in manufacturing, technical operations, process development and scale-up activities. As Executive Vice President, Technical Operations, he oversees Seattle Genetics' manufacturing, supply chain and quality assurance and control functions. Previously, Dr. Himes was with Zymogenetics, Inc., most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. While at Zymogenetics, he oversaw the chemistry, manufacturing and control (CMC) portion of the successful Biologics License Application for Recothrom and managed its commercial supply. Previously, he held Vice President positions in manufacturing and development at Corixa, Targeted Genetics and Genovo. Dr. Himes received a Bachelor of Arts in Chemistry from Pomona College in California and a Ph.D. in Chemical Engineering from the University of Minnesota.
| Organization |
Position |
Status |
| Seattle Genetics, Inc. |
Executive Vice President, Technical Operations |
Current |
| ZymoGenetics, Inc. |
Senior Vice President, Technical Operations |
Current |
| ZymoGenetics, Inc. |
Vice President, Commercial Manufacturing Operations |
Former |
| GSK Biologicals Seattle |
Vice President for Worldwide Manufacturing Operations |
Former |
| University of Minnesota |
PH.D. In Chemical Engineering |
Former |
| Pomona College |
Bachelor of Arts In Chemistry |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Piper Jaffray and Co. Edward Tenthoff |
Current |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Senior Regulatory Affairs Specialist |
Current |
| Mycodax |
Director |
Current |
| Viridax |
Board of Directors |
Current |
| San Jose State University |
BA In Biological Sciences |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Associate |
Current |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| ZymoGenetics, Inc. |
Manager, Communications |
Former |
| Organization |
Position |
Status |
| MannKind Corp. |
Board of Directors |
Current |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| Salomon Smith Barney |
Global Head of Health Care Investment Banking |
Former |
| UBS Securities LLC |
|
Former |
| Vital Signs, Inc. |
Director |
Current |
| New York University |
M.B.A. degree |
Former |
| Brown University |
A.B. |
Former |
| Organization |
Position |
Status |
| Columbia University |
Executive Vice President for Research |
Current |
| Warburg Pincus, LLC |
|
Current |
| Warburg, Pincus, LLC |
Life Sciences Advisory Board |
Current |
| The Rockefeller University |
Board Member |
Current |
| ZymoGenetics, Inc. |
Director |
Current |
| Synergen, Inc. |
Executive Vice President |
Former |
| Synergen, Inc. |
Director of Research |
Former |
| Salomon Smith Barney |
Global Head of Health Care Investment Banking |
Former |
| The Rockefeller University |
Ph.D. in Biochemistry |
Former |
| Reed College |
B.A. in Biology |
Former |
| Organization |
Position |
Status |
| Lilly Research Laboratories |
Group Vice President Global Marketing |
Current |
| Corcept Therapeutics Incorporated |
Board of Directors |
Current |
| ZymoGenetics, Inc. |
Director |
Current |
| Anesiva Inc. |
Board of Directors |
Current |
| Advanced Cardiovascular Systems, Inc. |
Chief Executive Officer |
Former |
| Advanced Cardiovascular Systems, Inc. |
President |
Former |
| Eli Lilly and Company |
Chief Marketing Officer |
Former |
| Eli Lilly and Company |
Vice President of Global Marketing |
Former |
| Wharton Graduate School of the University of Pennsylvania |
M.B.A. |
Former |
| Vanderbilt University |
B.A. |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Director |
Current |
| Inspire Pharmaceuticals, Inc. |
Director |
Current |
| InterMune, Inc. |
Director |
Current |
| Rib-X Pharmaceuticals |
Board of Directors |
Current |
| Allos Therapeutics, Inc. |
Director |
Current |
| Altus Pharmaceuticals Inc. |
Director |
Current |
| Neurogen Corporation |
Director |
Current |
| Sunesis Pharmaceuticals, Inc. |
Director |
Current |
| Oliver, Wyman & Company |
Consultant |
Former |
| Harvard University |
BA |
Former |
| Harvard College |
Ab In Government |
Former |
| Organization |
Position |
Status |
| Warburg, Pincus, LLC |
Managing Director Healthcare, Biotechnology, New York |
Current |
| Technology Vision Group LLC |
Managing Director at Warburg Pincus |
Current |
| Inspire Pharmaceuticals, Inc. |
Managing Director of Warburg Pincus |
Current |
| Warburg Pincus, LLC |
Managing Director |
Current |
| Allos Therapeutics, Inc. |
Partner, Warburg Pincus Llc |
Current |
| InterMune, Inc. |
Partner, Warburg Pincus Llc |
Current |
| Spinal Muscular Atrophy Foundation |
Head of Biotech Venture Capital, North America and |
Current |
| Warburg, Pincus, LLC |
Member of Executive Management Group |
Current |
| InterMune, Inc. |
Board of Directors |
Current |
| Sunesis Pharmaceuticals, Inc. |
Board of Directors |
Current |
| Technology Vision Group LLC |
Board of Directors |
Current |
| Allos Therapeutics, Inc. |
Board of Directors |
Current |
| Altus Co |
Board of Directors |
Current |
| Synaptic Pharmaceutical Corp |
Board of Directors |
Current |
| Rib-X Pharmaceuticals |
Director |
Current |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| Inspire Pharmaceuticals, Inc. |
Board of Directors |
Current |
| Spinal Muscular Atrophy Foundation |
Board of Directors |
Current |
| Warburg Pincus, LLC |
General Partner |
Former |
| Oliver, Wyman & Company |
Consultant |
Former |
| Stanford Graduate School of Business |
M.B.A. |
Former |
| Stanford University |
M.B.A. |
Former |
| Harvard College |
A.B. In Government |
Former |
| Harvard University |
B.A. In Government |
Former |
Array
| Organization |
Position |
Status |
| Renovis, Inc. |
Founder of Pharmion |
Current |
| Pharmion Corporation |
Board of Directors |
Current |
| Chroma Therapeutics Ltd |
Board of Directors |
Current |
| PRA International Inc. |
Board of Directors |
Current |
| The Perrigo Company |
Board of Directors |
Current |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| Pharmion Corporation |
Executive Vice President and Chief Operating Officer |
Former |
| AVAX Technologies, Inc. |
Senior Vice President, Business Development |
Former |
| Renovis, Inc. |
Consultant |
Former |
| Marion Laboratories |
Consultant |
Former |
| Hoechst Marion Roussel |
|
Former |
| Marion Merrell Dow |
|
Former |
| University of Missouri |
Ph.D. |
Former |
| Rockhurst University |
M.B.A. |
Former |
| Benedictine College |
B.S. Degree |
Former |
| University of Missouri |
B.S. In Biology |
Former |
| Rockhurst University |
B.S. In Biology |
Former |
| Pharmion Corporation |
Member |
Former |
| Organization |
Position |
Status |
| Norsk Hydro ASA |
Director |
Current |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| TDC A/S |
Director |
Current |
| Coloplast A/S |
Board of Directors |
Current |
| Booz Allen Hamilton, Inc. |
Management Consultant |
Former |
| Carlsberg A/S |
Business Economist |
Former |
| ZymoGenetics, Inc. |
Chairman |
Former |
| Novozymes A/S |
Vice Chairman |
Former |
| Novozymes A/S |
Director |
Former |
| Copenhagen Business School |
M.A. In Commerce |
Former |
| Copenhagen Business School |
B.A. In Economics |
Former |
| Norsk Hydro ASA |
member |
Former |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| ZymoGenetics, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| Principal Voices |
President and Chief Executive Officer of Danish Healthcare Giant Novo Nordisk A, S. |
Current |
| Global Diabetes Walk |
Board of Directors |
Current |
| World Diabetes Foundation |
Board of Directors |
Current |
| Bertelsmann AG |
Director |
Current |
| DONG Energy A/S |
Director |
Current |
| Scandinavian Airlines |
Board Member |
Current |
| ZymoGenetics, Inc. |
Board Member |
Current |
| Corporate Management Corp |
Board of Directors |
Former |
| Copenhagen Business School |
B.Sc. In International Economics |
Former |
Executive News
-
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
RBC Dain Raushcer - 6/10/09 - View Story
-
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
Stockwatch - 6/10/09 - View Story
-
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice
Business Wire via MSN Money - 6/10/09 - View Story
-
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
Business Wire - 6/10/09 - View Story
-
Best of the Web Today: La Jueza Empática
The Wall Street Journal Interactive Edition - 5/31/09 - View Story